U.S. Gas Utilities Stock News

A week ago, Puma Biotechnology, Inc. ( NASDAQ:PBYI ) came out with a strong set of first-quarter numbers that could...

It's been a sad week for Verastem, Inc. ( NASDAQ:VSTM ), who've watched their investment drop 18% to US$4.89 in the...

Airbnb, Inc. ( NASDAQ:ABNB ) came out with its first-quarter results last week, and we wanted to see how the business...

Westrock Coffee Company ( NASDAQ:WEST ) just released its latest quarterly results and things are looking bullish...

It's been a pretty great week for Corsair Gaming, Inc. ( NASDAQ:CRSR ) shareholders, with its shares surging 14% to...

A week ago, Assembly Biosciences, Inc. ( NASDAQ:ASMB ) came out with a strong set of quarterly numbers that could...

One thing we could say about the analysts on Daqo New Energy Corp. ( NYSE:DQ ) - they aren't optimistic, having just...

Cardlytics, Inc. ( NASDAQ:CDLX ) just released its latest first-quarter results and things are looking bullish...

Soft earnings didn't appear to concern General Motors Company's ( NYSE:GM ) shareholders over the last week. We think...

Anyone interested in Select Water Solutions, Inc. ( NYSE:WTTR ) should probably be aware that the Independent Director...

CytomX Therapeutics, Inc. ( NASDAQ:CTMX ) defied analyst predictions to release its first-quarter results, which were...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Iovance Biotherapeutics, Inc. ( NASDAQ:IOVA ) missed earnings with its latest first-quarter results, disappointing...

SolarEdge Technologies, Inc. ( NASDAQ:SEDG ) last week reported its latest quarterly results, which makes it a good...

There's been a major selloff in Akebia Therapeutics, Inc. ( NASDAQ:AKBA ) shares in the week since it released its...

PubMatic, Inc. ( NASDAQ:PUBM ) defied analyst predictions to release its first-quarter results, which were ahead of...

Last week saw the newest first-quarter earnings release from Fortune Brands Innovations, Inc. ( NYSE:FBIN ), an...

Gevo, Inc. ( NASDAQ:GEVO ) just released its latest first-quarter report and things are not looking great. Revenues...

There's been a major selloff in HubSpot, Inc. ( NYSE:HUBS ) shares in the week since it released its first-quarter...

Stock performance snapshot Horace Mann Educators (HMN) has moved relatively quietly in recent weeks, with the stock edging up about 1% over the past month and about 4% over the past 3 months. For longer term holders, the stock shows a 9% total return over the past year and roughly 50% over the past 3 years, while year to date it is down about 1%. See our latest analysis for Horace Mann Educators. At a share price of $44.51, Horace Mann Educators has experienced some short-term share price...

CF Industries Holdings, Inc. ( NYSE:CF ) is about to trade ex-dividend in the next three days. The ex-dividend date is...

Stronger quarter and completed buyback put Ecovyst stock in focus Ecovyst (ECVT) has drawn fresh attention after first quarter 2026 results showed sales of US$214.95 million and a return to profitability, alongside completion of a multi year US$303.47 million share repurchase program. See our latest analysis for Ecovyst. The stronger first quarter and sizeable completed buyback appear to sit behind Ecovyst’s recent momentum, with a 90 day share price return of 26.25% and a 1 year total...

In April 2026, Sabra Health Care REIT, Inc. reported first-quarter results showing revenue of US$221.75 million and net income of US$40.88 million, alongside a slight year-on-year decrease in earnings per share from continuing operations to US$0.16. On the same day, the company also affirmed a quarterly dividend of US$0.30 per share, signaling ongoing cash returns to shareholders despite modest per‑share earnings pressure. Next, we’ll examine how Sabra’s higher quarterly revenue alongside...

Collegium Pharmaceutical (COLL) is back in focus after reporting first quarter 2026 earnings that showed a sharp jump in profitability and progress across its ADHD and pain portfolios, alongside a proposed AZSTARYS acquisition. See our latest analysis for Collegium Pharmaceutical. Despite the strong first quarter earnings and the proposed AZSTARYS deal, Collegium Pharmaceutical’s share price performance has been mixed. The 7 day share price return was 9.31%, but the 90 day share price return...